Molecular aberrations in myelodysplastic syndromes
- 13 April 2020
- journal article
- expert perspective
- Published by Wiley in Advances in Cell and Gene Therapy
- Vol. 4 (3)
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Role of RUNX1 in hematological malignanciesBlood, 2017
- Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteinsNature Medicine, 2016
- Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromesLeukemia, 2015
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesBlood, 2015
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromesLeukemia, 2013
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsNew England Journal of Medicine, 2011
- Unraveling the Molecular Pathophysiology of Myelodysplastic SyndromesJournal of Clinical Oncology, 2011
- Advancements in the molecular pathogenesis of myelodysplastic syndromeCurrent Opinion in Hematology, 2009
- The myelodysplastic syndromes: Diagnosis, molecular biology and risk assessmentHematology, 2005